Capillary electrophoresis method for plasmatic determination of imatinib mesylate in chronic myeloid leukemia patients. (Q54578490)

1 June 2018

title

Capillary electrophoresis method for plasmatic determination of imatinib mesylate in chronic myeloid leukemia patients. (English)

1 reference

1 June 2018

main subject

chronic myeloid leukemia

0 references

1 reference

Tatiana O Ajimura

1 reference

1 June 2018

Keyller B Borges

1 reference

1 June 2018

Aline F Ferreira

1 reference

1 June 2018

Fabíola A de Castro

1 reference

1 June 2018

Cristiane M de Gaitani

1 reference

1 June 2018

publication date

24 June 2011

1 reference

1 June 2018

published in

Electrophoresis

1 reference

1 June 2018

volume

1 reference

1 June 2018

issue

1 reference

1 June 2018

page(s)

1885-1892

1 reference

1 June 2018

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

cites work

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Specific targeted therapy of chronic myelogenous leukemia with imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Pharmacologic monitoring and determinants of intracytoplasmic drug levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

A validated LC method for imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Reversed-phase liquid chromatography analysis of imatinib mesylate and impurity product in Glivec capsules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Experimental design in reversed-phase high-performance liquid chromatographic analysis of imatinib mesylate and its impurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Identification of imatinib mesylate degradation products obtained under stress conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Development and validation of a simple liquid chromatographic method with ultraviolet detection for the determination of imatinib in biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Determination of imatinib mesylate and its main metabolite (CGP74588) in human plasma and murine specimens by ion-pairing reversed-phase high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Determination of imatinib plasma levels in patients with chronic myeloid leukemia by high performance liquid chromatography-ultraviolet detection and liquid chromatography-tandem mass spectrometry: methods' comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Imatinib assay by HPLC with photodiode-array UV detection in plasma from patients with chronic myeloid leukemia: Comparison with LC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Simultaneous determination of nilotinib, imatinib and its main metabolite (CGP-74588) in human plasma by ultra-violet high performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Quantification of the anti-leukemia drug STI571 (Gleevec) and its metabolite (CGP 74588) in monkey plasma using a semi-automated solid phase extraction procedure and liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

High-throughput quantification of the anti-leukemia drug STI571 (Gleevec) and its main metabolite (CGP 74588) in human plasma using liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Quantification of the anticancer agent STI-571 in erythrocytes and plasma by measurement of sediment technology and liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Quantification of imatinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Direct and fast capillary zone electrophoretic method for the determination of Gleevec and its main metabolite in human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Nonaqueous capillary electrophoresis method for the analysis of gleevec and its main metabolite in human urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Capillary electrophoresis as a versatile tool for the bioanalysis of drugs--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

7 January 2021

inferred from DOI database lookup

Stability-indicating HPTLC determination of imatinib mesylate in bulk drug and pharmaceutical dosage form

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

7 January 2021

inferred from DOI database lookup

Simultaneous determination of AMN107 and Imatinib (Gleevec, Glivec, STI571) in cultured tumour cells using an isocratic high-performance liquid chromatography procedure with UV detection

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201000642

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/ELPS.201000642

1 reference

1 June 2018

release_soowplcce5ffrfchwgsvpn76bq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/soowplcce5ffrfchwgsvpn76bq

24 November 2022

mapped directly with Wikidata item

1 reference

1 June 2018